Fig. 4From: A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infectionThe nomograms (a) are used to estimate OS for NSCLC (HBV+) patients, along with the calibration plot (b–d) for the nomograms at 1-, 3-, 5- year in training cohort (left) and validation cohort (right)Back to article page